Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2/3 1Phase 2 1

Status

Unknown 4Completed 4Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 4

Conditions

Breast Neoplasms 47Carcinoma, Hepatocellular 9Triple Negative Breast Neoplasms 7Stomach Neoplasms 6Inflammatory Breast Neoplasms 6Lymphoma, Large B-Cell, Diffuse 4Urinary Bladder Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 3Esophageal Neoplasms 3Recurrence 2Lymphoma 2Breast Neoplasms, Male 2Breast Diseases 2Upper Tract Urothelial Carcinoma 1Thymoma 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Pancreatic Neoplasms 1Oesophagogastric Cancer 1Neoplastic Cells, Circulating 1Neoplasms, Unknown Primary 1Neoplasms 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lung Neoplasms 1Liver Neoplasms 1Leiomyosarcoma 1

Interventions

Rituximab 57Cyclophosphamide 40Vincristine 26Prednisone 25Doxorubicin 22Cytarabine 18Lenalidomide 17Etoposide 17Gemcitabine 12Melphalan 8Filgrastim 8Cisplatin 8zanubrutinib 7Peripheral Blood Stem Cell Transplantation 7Oxaliplatin 7N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 7Methotrexate 7Ifosfamide 7Carmustine 7R-CHOP protocol 6fludarabine phosphate 5Vindesine 5Radiotherapy 5Dexamethasone 5Decitabine 5Busulfan 5ibrutinib 4Methylprednisolone 4Epirubicin 4Cyclosporine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Lymphoma, Large B-Cell, Diffuse × Epirubicin × Clear all
NCT05887726 2023-07-27

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Liaoning Cancer Hospital & Institute

Phase 2 Unknown
30 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02752815 2022-12-05

Reduced Chemotherapy in Low Risk DLBCL

Ruijin Hospital

Phase 4 Unknown
290 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT02871869 2017-07-17

Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

Xinjiang Medical University

Phase 2/3 Unknown
316 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT03022123 2017-01-16

The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma

Hebei Medical University Fourth Hospital

Phase NA Unknown
270 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡